NCT00950144
- Conditions
- Adenocarcinoma, Behavior, Behavioral Symptoms, +32 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
Clinical trial condition
Depression
Explore clinical trials studying Depression. Study availability and eligibility vary by location and protocol.
3,571 public trials
433 recruiting studies
Depression trial results
NCT00619619
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- Pfizer Investigational Site Little Rock, Arkansas, United States
- Pfizer Investigational Site North Miami, Florida, United States
- Pfizer Investigational Site Terre Haute, Indiana, United States
- Pfizer Investigational Site Wichita, Kansas, United States
Completed
Multiple-Ascending Dose Study
NCT00892840
- Conditions
- Behavior, Behavioral Symptoms, Depression
- Locations
-
- Local Institution Uppsala, Sweden
NCT00152763
- Conditions
- Anxiety, Anxiety Disorders, Behavior, +3 more
- Locations
-
- Toronto General Hospital Toronto, Ontario, Canada
NCT00949767
- Conditions
- Behavior, Behavioral Symptoms, Depression
- Locations
-
- Local Institution Uppsala, Sweden
Completed
Single Dose Study of BMS-820836
NCT00964912
- Conditions
- Behavior, Behavioral Symptoms, Depression
- Locations
-
- Local Institution Toronto, Ontario, Canada
NCT00491686
- Conditions
- Behavior, Behavioral Symptoms, Depression
- Locations
-
- Research Site Glendale, California, United States
- Research Site Hartford, Connecticut, United States
- Research Site New Haven, Connecticut, United States
- Research Site Wichita, Kansas, United States
Completed
The Efficacy of Omega-3 Fatty Acids in Maintaining Optimal Mental Health in Elderly People
NCT00124852
- Conditions
- Behavior, Behavioral Symptoms, Cognition Disorders, +5 more
- Locations
-
- Wageningen University Wageningen, Gelderland, Netherlands
NCT00788944
- Conditions
- Behavior, Behavioral Symptoms, Depression
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Tuscon, Arizona, United States
- Pfizer Investigational Site Little Rock, Arkansas, United States
- Pfizer Investigational Site National City, California, United States
NCT00446719
- Conditions
- Anxiety Disorders, Behavior, Behavioral Symptoms, +5 more
- Locations
-
- Mount Sinai Hospital Toronto, Ontario, Canada